18537704. ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL simplified abstract (FUJIFILM CORPORATION)
Contents
- 1 ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL
Organization Name
Inventor(s)
Mamoru Kuramoto of Kanagawa (JP)
ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL - A simplified explanation of the abstract
This abstract first appeared for US patent application 18537704 titled 'ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL
Simplified Explanation
The abstract of the patent application describes an endoscopic submucosal injection material containing water and a polysaccharide represented by Formula (1).
- The innovation involves an endoscopic submucosal injection material for medical procedures.
- The material consists of water and a polysaccharide represented by Formula (1).
Potential Applications
The technology can be used in endoscopic procedures for submucosal injections, such as in the treatment of gastrointestinal conditions.
Problems Solved
This technology provides a safe and effective material for submucosal injections during endoscopic procedures, improving patient outcomes and reducing risks.
Benefits
- Improved precision and control during endoscopic procedures - Enhanced safety for patients undergoing submucosal injections - Potential for better treatment outcomes due to the properties of the polysaccharide material
Potential Commercial Applications
"Endoscopic Submucosal Injection Material for Medical Procedures" can be used in gastroenterology clinics, hospitals, and other medical facilities offering endoscopic services.
Possible Prior Art
There may be prior art related to endoscopic injection materials or polysaccharide-based solutions used in medical procedures.
Unanswered Questions
How does this technology compare to existing endoscopic injection materials on the market?
This article does not provide a direct comparison with other endoscopic injection materials available, leaving room for further research and analysis.
What are the long-term effects of using this polysaccharide-based material in endoscopic procedures?
The potential long-term effects of using this specific polysaccharide material in endoscopic procedures are not addressed in this article, warranting further investigation and clinical studies.
Original Abstract Submitted
An endoscopic submucosal injection material containing: water; and a polysaccharide represented by Formula (1) is provided:
